Z
Zheng Xu
Researcher at United States Military Academy
Publications - 4
Citations - 1240
Zheng Xu is an academic researcher from United States Military Academy. The author has contributed to research in topics: Immunology & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 1233 citations.
Papers
More filters
Journal ArticleDOI
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
John W. Shiver,Tong-Ming Fu,Ling Chen,Danilo R. Casimiro,Mary-Ellen Davies,Robert K. Evans,Zhiqiang Zhang,Adam J. Simon,Wendy L. Trigona,Sheri Dubey,Lingyi Huang,Virginia Harris,Romnie Long,Xiaoping Liang,Larry Handt,William A. Schleif,Lan Zhu,Daniel C. Freed,Natasha Persaud,Liming Guan,Kara Punt,Aimin Tang,Minchun Chen,Keith A. Wilson,Kelly B. Collins,Gwendolyn J. Heidecker,V. Rose Fernandez,Helen C. Perry,Joseph G. Joyce,Karen M. Grimm,James C. Cook,Paul M. Keller,Denise S. Kresock,Henryk Mach,Robert D. Troutman,Lynne Isopi,Donna M. Williams,Zheng Xu,Kathryn E. Bohannon,David B. Volkin,David C. Montefiori,Ayako Miura,Georgia R. Krivulka,Michelle A. Lifton,Marcelo J. Kuroda,Jörn E. Schmitz,Norman L. Letvin,Michael J. Caulfield,Andrew J. Bett,Rima Youil,David C. Kaslow,Emilio A. Emini +51 more
TL;DR: The replication-defective adenovirus is a promising vaccine vector for development of an HIV-1 vaccine and elicited by a replication-incompetent Ad5 vector, used either alone or as a booster inoculation after priming with a DNA vector.
Journal ArticleDOI
Development of an effective one-step double-antigen sandwich ELISA based on p72 to detect antibodies against African swine fever virus
TL;DR: Wang et al. as discussed by the authors developed a one-step double-antigen sandwich enzyme-linked immunosorbent assay (one-step DAgS-ELISA) for detecting ASFV antibodies.
Journal ArticleDOI
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
TL;DR: In this article , the association between tumor microenvironment (TME) and immunotherapy in lung cancer was discussed, and the authors concluded that targeting TME by nanoparticles could help to overcome resistance to PD-1/PD-L1 blockade.
Journal ArticleDOI
Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
TL;DR: In this paper , the authors summarized and discussed the recent research progresses of the neoantigen, peptide-based peptide vaccines, and DC-based vaccine in pancreatic cancers (PCs).